These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36193936)

  • 1. Residual Risk of Trimethylamine-N-Oxide and Choline for Stroke Recurrence in Patients With Intensive Secondary Therapy.
    Xue J; Xu J; Zhao M; Jin A; Cheng A; Jiang X; Li K; Lin J; Meng X; Li H; Zheng L; Wang Y
    J Am Heart Assoc; 2022 Oct; 11(19):e027265. PubMed ID: 36193936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
    Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS
    J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethylamine N-Oxide and Stroke Recurrence Depends on Ischemic Stroke Subtypes.
    Xu J; Cheng A; Song B; Zhao M; Xue J; Wang A; Dai L; Jing J; Meng X; Li H; Zheng L; Wang Y
    Stroke; 2022 Apr; 53(4):1207-1215. PubMed ID: 34794334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
    Haghikia A; Li XS; Liman TG; Bledau N; Schmidt D; Zimmermann F; Kränkel N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Fraccarollo D; Heimesaat MM; Bauersachs J; Wang Z; Zhu W; Bavendiek U; Hazen SL; Endres M; Landmesser U
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2225-2235. PubMed ID: 29976769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke.
    Sun T; Zhang Y; Yin J; Peng X; Zhou L; Huang S; Wen Y; Cao B; Chen L; Li X; Yang W; Tan A; Cheng J; Liu L
    J Atheroscler Thromb; 2021 Apr; 28(4):320-328. PubMed ID: 32641646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship of Large-Artery Atherothrombotic Stroke with Plasma Trimethylamine N-Oxide Level and Blood Lipid-Related Indices: A Cross-Sectional Comparative Study.
    Xu D; Zhao W; Song J; Yin L; Wang K; Wei L; Xu Y; Li H; Min B; Tang N; Jiang X; Liu H; Yan S; Leng H; Xue Q; Peng M; Wang H
    Biomed Res Int; 2021; 2021():5549796. PubMed ID: 33977104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
    Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.
    Zhang J; Wang L; Cai J; Lei A; Liu C; Lin R; Jia L; Fu Y
    J Neuroimmunol; 2021 May; 354():577526. PubMed ID: 33647820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMAO as a Novel Predictor of Major Adverse Vascular Events and Recurrence in Patients with Large Artery Atherosclerotic Ischemic Stroke.
    Chen YY; Ye ZS; Xia NG; Xu Y
    Clin Appl Thromb Hemost; 2022; 28():10760296221090503. PubMed ID: 35345908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
    Lemaitre RN; Jensen PN; Wang Z; Fretts AM; McKnight B; Nemet I; Biggs ML; Sotoodehnia N; de Oliveira Otto MC; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    JAMA Netw Open; 2021 Aug; 4(8):e2122844. PubMed ID: 34448864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke.
    Hou L; Zhang Y; Zheng D; Shi H; Zou C; Zhang H; Lu Z; Du H
    Neurol Res; 2020 Feb; 42(2):153-158. PubMed ID: 31928326
    [No Abstract]   [Full Text] [Related]  

  • 12. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack.
    Yin J; Liao SX; He Y; Wang S; Xia GH; Liu FT; Zhu JJ; You C; Chen Q; Zhou L; Pan SY; Zhou HW
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26597155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients.
    Li J; Pan Y; Xu J; Li S; Wang M; Quan K; Meng X; Li H; Lin J; Wang Y; Zhao X; Liu L; Wang Y;
    Stroke; 2021 Aug; 52(9):2827-2836. PubMed ID: 34281380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
    Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days.
    Schneider C; Okun JG; Schwarz KV; Hauke J; Zorn M; Nürnberg C; Ungerer M; Ringleb PA; Mundiyanapurath S
    Eur J Neurol; 2020 Aug; 27(8):1596-1603. PubMed ID: 32282978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients.
    Nie J; Xie L; Zhao BX; Li Y; Qiu B; Zhu F; Li GF; He M; Wang Y; Wang B; Liu S; Zhang H; Guo H; Cai Y; Huo Y; Hou FF; Xu X; Qin X
    Stroke; 2018 Sep; 49(9):2021-2028. PubMed ID: 30354996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis.
    Witkowski M; Witkowski M; Friebel J; Buffa JA; Li XS; Wang Z; Sangwan N; Li L; DiDonato JA; Tizian C; Haghikia A; Kirchhofer D; Mach F; Räber L; Matter CM; Tang WHW; Landmesser U; Lüscher TF; Rauch U; Hazen SL
    Cardiovasc Res; 2022 Jul; 118(10):2367-2384. PubMed ID: 34352109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
    Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
    Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The associations between TMAO-related metabolites and blood lipids and the potential impact of rosuvastatin therapy.
    Xiong X; Zhou J; Fu Q; Xu X; Wei S; Yang S; Chen B
    Lipids Health Dis; 2022 Jul; 21(1):60. PubMed ID: 35864500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.
    Wangqin R; Wang X; Wang Y; Xian Y; Zhao X; Liu L; Li H; Meng X; Wang Y
    Stroke Vasc Neurol; 2017 Dec; 2(4):176-183. PubMed ID: 29507777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.